100 related articles for article (PubMed ID: 27364103)
1. Production lost due to cervical cancer in Poland in 2012.
Dubas-Jakóbczyk K; Kocot E; Seweryn M; Koperny M
Med Pr; 2016; 67(3):289-99. PubMed ID: 27364103
[TBL] [Abstract][Full Text] [Related]
2. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
4. Annual productivity costs due to cervical cancer mortality in the United States.
Insinga RP
Womens Health Issues; 2006; 16(5):236-42. PubMed ID: 17055376
[TBL] [Abstract][Full Text] [Related]
5. [The cost of schizophrenia: a literature review].
Charrier N; Chevreul K; Durand-Zaleski I
Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
[TBL] [Abstract][Full Text] [Related]
6. Indirect costs and incidence of caregivers' short-term absenteeism in Poland, 2006-2016.
Łyszczarz B
BMC Public Health; 2019 May; 19(1):598. PubMed ID: 31101035
[TBL] [Abstract][Full Text] [Related]
7. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
Łyszczarz B; Nojszewska E
BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
[TBL] [Abstract][Full Text] [Related]
8. The organization and financing of cervical cancer prevention carried out by midwives in primary health care.
Sobczyk K; Woźniak-Holecka J; Holecki T; Szałabska D
Ginekol Pol; 2016; 87(12):798-804. PubMed ID: 28098929
[TBL] [Abstract][Full Text] [Related]
9. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
Holko P; Kawalec P; Mossakowska M; Pilc A
PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
[TBL] [Abstract][Full Text] [Related]
10. Indirect costs of cervical and breast cancers in Spain.
Oliva J; Lobo F; López-Bastida J; Zozaya N; Romay R
Eur J Health Econ; 2005 Dec; 6(4):309-13. PubMed ID: 16133097
[TBL] [Abstract][Full Text] [Related]
11. [Treatment costs of malignant cervical cancer in Poland in 2011-2012--the case of Silesian Voivodeship].
Holecki T; Sobczyk K; Nawrocki S; Woźniak-Holecka J; Skrzypek M; Bocionek A
Ginekol Pol; 2015 Nov; 86(11):849-55. PubMed ID: 26817317
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the National Population-Based Cervical Cancer Screening Programme in Poland--outcomes, problems and possible solutions 7 years after implementation.
Januszek-Michalecka L; Nowak-Markwitz E; Banach P; Spaczynski M
Ann Agric Environ Med; 2013; 20(4):859-64. PubMed ID: 24364469
[TBL] [Abstract][Full Text] [Related]
13. Indirect costs of diabetes and its impact on the public finance: the case of Poland.
Torój A; Mela A
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563
[TBL] [Abstract][Full Text] [Related]
14. [Cost of lost productivity in pharmacoeconomics analysis. Part II. Survey in the expert group].
Wrona W; Hermanowski T; Jakubczyk M; Golicki D; Czech M; Niewada M; Kolasa K
Przegl Epidemiol; 2011; 65(1):153-7. PubMed ID: 21735853
[TBL] [Abstract][Full Text] [Related]
15. Costs of depression in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
[TBL] [Abstract][Full Text] [Related]
16. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
17. Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil.
Novaes HM; Itria A; Silva GA; Sartori AM; Rama CH; Soárez PC
Clinics (Sao Paulo); 2015 Apr; 70(4):289-95. PubMed ID: 26017797
[TBL] [Abstract][Full Text] [Related]
18. [Cost of lost productivity in pharmacoeconomics analysis. Part I. A systematic review of the literature].
Wrona W; Hermanowski T; Golicki D; Jakubczyk M; Macioch T; Goszczyńska K; Wójcik R
Przegl Epidemiol; 2011; 65(1):147-52. PubMed ID: 21735852
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
Perovic S
J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
